Vanguard Capital Management’s Beneficient BENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-153,491
Closed -$565K – 4082
2026
Q2
$565K Buy
153,491
+3,491
+2% +$12.1K ﹤0.01% 3695
2026
Q1
$525K Buy
+150,000
New +$650K ﹤0.01% 3664

Other funds holding BENF

Vanguard Capital Management's BENF Position: Q3 2026 in Review

Vanguard Capital Management sold out of Beneficient (BENF) in Q3 2026, closing a stake of 153,491 shares — an estimated $565K sold.

Vanguard Capital Management first reported a position in BENF in Q1 2026 and held it in 2 quarters. The position peaked at $565K in Q2 2026. 14 funds tracked by Wall St. Rank hold BENF as of Q3 2026.

  • Vanguard Capital Management reported no remaining Beneficient position as of Q3 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 153,491 Beneficient shares in Q3 2026, an estimated $565K.
  • Vanguard Capital Management first reported a position in Beneficient in Q1 2026 and held it in 2 quarters.
  • Vanguard Capital Management's Beneficient position peaked at $565K in Q2 2026.
  • 14 funds tracked by Wall St. Rank held Beneficient as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.